These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30817108)

  • 1. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.
    Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F
    ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased NURR1 gene expression in patients with Parkinson's disease.
    Le W; Pan T; Huang M; Xu P; Xie W; Zhu W; Zhang X; Deng H; Jankovic J
    J Neurol Sci; 2008 Oct; 273(1-2):29-33. PubMed ID: 18684475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
    Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A
    Neurotox Res; 2016 Oct; 30(3):338-44. PubMed ID: 27159982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients' studies in Parkinson's disease.
    Li T; Tan X; Tian L; Jia C; Cheng C; Chen X; Wei M; Wang Y; Hu Y; Jia Q; Ni Y; Al-Nusaif M; Li S; Le W
    J Neuroinflammation; 2023 Nov; 20(1):274. PubMed ID: 37990334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of
    Li T; Yang Z; Li S; Cheng C; Shen B; Le W
    Front Aging Neurosci; 2018; 10():392. PubMed ID: 30555319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker.
    Yang Z; Li T; Cui Y; Li S; Cheng C; Shen B; Le W
    Front Neurosci; 2019; 13():218. PubMed ID: 30936821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J; Chen C; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
    Ozdilek B; Demircan B
    Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.
    Zhang LM; Sun CC; Mo MS; Cen L; Wei L; Luo FF; Li Y; Li GF; Zhang SY; Yi L; Huang W; Liu ZL; Le WD; Xu PY
    Chin Med J (Engl); 2015 Jul; 128(13):1755-60. PubMed ID: 26112716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Cao XY; Lu JM; Zhao ZQ; Li MC; Lu T; An XS; Xue LJ
    Neurosci Lett; 2017 Mar; 644():94-99. PubMed ID: 28223160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
    Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
    Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model.
    Lungu G; Stoica G; Ambrus A
    Neurosci Lett; 2013 Oct; 553():153-8. PubMed ID: 23973300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
    Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
    Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-221 serves as a biomarker for Parkinson's disease.
    Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
    Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease.
    Liu H; Wei L; Tao Q; Deng H; Ming M; Xu P; Le W
    Eur J Neurol; 2012 Jun; 19(6):870-5. PubMed ID: 22309633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.